Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper-Reference-Cited by-同舟云学术

Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper

Published:2020-10 Issue: Volume:154 Page:103066
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Silvestris Nicola^ORCID,Argentiero Antonella,Beretta Giordano Domenico,Di Bartolo Paolo,Montagnani Monica^ORCID,Danesi Romano,Ferrari Pietro,D’Oronzo Stella,Gori Stefania,Russo Antonio^ORCID,Acquati Silvia,Gallo Marco

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference81 articles.

1. Association between treatment toxicity and outcomes in oncology clinical trials;Abola;Ann Oncol,2014

2. Impact of patient ethnicity on the metabolic and immunologic effects of PI3K-mTOR pathway inhibition in patients with solid tumor malignancies;Aggarwal;Cancer Chemother Pharmacol,2014

3. Immune checkpoint inhibitor-induced Type 1 diabetes: a systematic review and meta-analysis;Akturk;Diabet Med,2019

4. Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4;Attia;J Clin Oncol,2005

5. Evidence for rapamycin toxicity in pancreatic beta-cells and a review of the underlying molecular mechanisms;Barlow;Diabetes,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic effect of cancer therapy;Metabolomics of Bladder Cancer;2025

2. Glycemic control and cancer outcomes in oncologic patients with diabetes: an Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE), Italian Society of Pharmacology (SIF) multidisciplinary critical view;Journal of Endocrinological Investigation;2024-06-27

3. Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper;ESMO Open;2023-12

4. Hyperglycemic crisis associated with immune-checkpoint inhibitors therapy: Report of three cases;Medicina Clínica;2023-03

5. Hyperglycemic crisis associated with immune-checkpoint inhibitors therapy: Report of three cases;Medicina Clínica (English Edition);2023-03